(Q43406007)

English

Report of the Cent Gardes HIV Vaccine Conference: The B-cell response to HIV. Part 2: Non-neutralizing antibodies: Fondation Mérieux Conference Center, Veyrier du Lac, France 5-7 November 2012.

scientific article published on 18 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Report of the Cent Gardes HIV Vaccine Conference: The B-cell response to HIV. Part 2: Non-neutralizing antibodies: Fondation Mérieux Conference Center, Veyrier du Lac, France 5-7 November 2012. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Valentina Picot

2

object named as

Valentina Picot

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

4

object named as

Gary J Nabel

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

author name string

Marc P Girard

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Christophe Longuet

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

language of work or name

0 references

publication date

18 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

2984-2987

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Report of the Cent Gardes HIV Vaccine Conference: The B-cell Response to HIV. Part 1: Broadly Neutralizing Antibodies Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 November 2012

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.067

7 January 2021

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.067

7 January 2021

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.067

7 January 2021

An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.067

7 January 2021

Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.067

7 January 2021

HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.067

7 January 2021

Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.067

7 January 2021

Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.067

7 January 2021

Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.067

7 January 2021

Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.067

7 January 2021

Setting the stage: host invasion by HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.067

7 January 2021

Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.067

7 January 2021

Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.067

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.02.067

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43406007&oldid=1610639419"